Diabetes Therapeutics Market Anticipated to Hit $186,842 Mn by 2023, at a CAGR of 16%
Pharmacological research is the most promising method to reduce the burden of type 2 diabetes globally. This has led to an increase in R&D activities in the diabetes drugs sector, which has resulted in the development of new variants of antidiabetic agents.
Diabetes Therapeutics Market was valued at $66,993 million in 2016, and is estimated to reach $186,842 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/3542
The major factor that contributes to the market growth are increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, development of affordable & effective diabetes therapeutics, rise in obese population, consumption of fast food, growth in awareness among people about self-management of diabetes, and support from the government further boost the market growth.
Key Findings of the Diabetes Therapeutics Market
The injectables segment accounted for nearly two-thirds share of the global market in 2016. GLP-1 receptor agonists segment expected to grow at a rapid CAGR of 33.1% from 2017 to 2023. Insulin segment accounted for more than half of the global market in 2016. Asia-Pacific is expected to grow at the highest CAGR of 16.8% from 2017 to 2023.
The major companies profiled in the report include
Boehringer Ingelheim GmbH
Eli Lilly and Company
Johnson & Johnson
Merck & Co., Inc.
Takeda Pharmaceutical Company Limited
Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/354
Table of Content
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
22.214.171.124. Competitive intelligence of companies and their strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.4. Impact analysis
3.5. CLINICAL TRIALS